A Phase 1b/2 Trial Evaluating Safety and Efficacy of CAPecitabine in Combination With Ni-rapaRIb in HER2-negative Advanced Breast canCEr
Clinical trial NCT05519670 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05519670
- Sponsor
- Institut Paoli-Calmettes
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2027-09-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.